FAS and autoimmune lymphoproliferative syndrome: For instance, patients with autoimmune lymphoproliferative syndrome (ALPS), caused by germline and somatic TNFRSF6 mutations, are more prone to develop severe persistent hypogammaglobulinemia after rituximab treatment, and splenectomy is contraindicated.